EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review

K Nagaraj Pai, K Subrahmanya Bhat iD

RSC Advances · 2026 · 16 (35) · 34023-34064

DOI: 10.1039/d6ra03227c ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Advances, 2026. Verfasst von K Nagaraj Pai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Manipal Institute of Technology, Manipal Academy of Higher Education Manipal-576104 India subrahmanya.bhat@manipal.edu. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthesis of hydrazone derivatives and anticancer activities of quinoline-, indole-, triazole-, benzimidazole- and isatin-based hydrazone derivatives.

Autor:innen und Institutionen

  • Manipal Institute of Technology, Manipal Academy of Higher Education Manipal-576104 India subrahmanya.bhat@manipal.edu.

ORCID-Profile: K Subrahmanya Bhat

Zitieren

APA

Pai, K. N., & Bhat, K. S. (2026). Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review. RSC Advances, 16(35), 34023-34064. https://doi.org/10.1039/d6ra03227c

Vancouver

Pai KN, Bhat KS. Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review. RSC Advances. 2026;16(35):34023-34064. doi:10.1039/d6ra03227c

BibTeX
@article{Pai2026,
  author = {Pai, K Nagaraj and Bhat, K Subrahmanya},
  title = {Hydrazone–heterocyclic hybrids as promising anticancer agents: a comprehensive review},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {35},
  pages = {34023--34064},
  doi = {10.1039/d6ra03227c}
}
Kostenlos starten →